Social proof · Anonymized composites
What chart review surfaces in practice
These are aggregated, de-identified examples from RevOptix1 and expert review workflows. Outcomes vary by
facility, census mix, and documentation culture. Illustrative recovery modeling is not a guarantee.
Composite A · Pacific Northwest · ~95 beds
Documentation alignment review (12 stays)
4 of 12 stays (33%)
Supported additional or corrected PDPM-relevant coding when notes were reconciled to transmitted MDS.
Primary themes: NTA under-capture, GG/ADL inconsistency, SLP indicators in notes but not on Section I.
Read regional brief →
Composite B · Single-stay deep dive
Stay ST-0047 (anonymized)
1 NTA gap · source-documented
Physician H&P and nursing notes supported COPD/NTA indicator not reflected on MDS at transmission.
Finding tied to specific note dates — not a suggested code without chart evidence.
View sample report →
Illustrative recovery modeling
Bed-count tier range
$234K – $690K / yr
Modeled from documented ICD-10/PDPM gaps on representative stays at RevOptix1 subscription tiers (under 75
through 201+ beds). Dollar impact depends on census, case-mix, and MAC rates — verify with your CFO using
your own chart sample.
See methodology →
“Tried several consultants before — PDPM Audit Optimization Group’s data analysis and training
truly stand out. Insightful, practical, they really know their stuff.”
Cynthia Jones, Administrator, Long-Term Care
“PDPM Audit Optimization Group gave us something we didn’t realize we needed: a private, clear read on what was actually in our charts. The findings were specific, practical, and immediately useful for both compliance and reimbursement.”
Jamie Hanks, DON
“What impressed us most was the confidentiality. We were able to review a single chart without creating internal friction, and the results showed exactly where documentation was costing us revenue and audit risk.”
Sydnee Hansen, LPN
Composite and illustrative data only. Not legal, medical, or billing advice. Not a guarantee of recovery,
survey outcome, or audit result. Start the $550/mo Pilot on RevOptix1 to compare findings against your internal QA.